Faeth Therapeutics, Inc.
FTH
$32.34
$3.7913.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -224.29% | -2,380.13% | 39.29% | 37.02% | 30.89% |
| Total Depreciation and Amortization | -32.43% | -11.76% | -89.73% | -89.76% | -88.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 701.05% | 24,463.53% | -61.85% | -43.51% | -48.99% |
| Change in Net Operating Assets | -136.56% | 1,650.64% | 14.40% | -22.22% | -1,850.59% |
| Cash from Operations | -165.24% | -51.30% | 33.29% | 34.44% | -2.02% |
| Capital Expenditure | 100.00% | -- | -- | -- | 85.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,362.01% | -629.91% | 166.04% | -86.50% | 22.05% |
| Cash from Investing | -1,334.05% | -537.16% | 166.04% | -86.50% | 26.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 94.27% | 70.62% | 45.41% | 25.49% | -56.22% |
| Issuance of Common Stock | 1,860.00% | -- | -84.62% | -- | -76.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,350.35% | -- | -- | -- | -- |
| Cash from Financing | -901.79% | 86,934.58% | 42.78% | 25.49% | 6.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,779.93% | 122,883.76% | 79.27% | -127.56% | 186.63% |